In conclusion, ALK‐positive lung cancer patients exhibit higher CYFRA21‐1 positivity and have higher CYFRA21‐1:CEA ratios compared with EGFR‐positive lung cancer patients. This evidence concerns the gene CEACAM5 and lung carcinoma.